Drug Type Small molecule drug |
Synonyms EFIL 301, EFIL301 |
Action inhibitors |
Mechanism Acyl coenzyme A:cholesterol acyltransferase inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Castration-Resistant Prostatic Cancer | Preclinical | South Korea | 01 May 2023 |





